NCT00687193 - Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan | Biotech Hunter

Enrollment

318

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Arthritis, Rheumatoid

Interventions

DRUG

Placebo

Placebo BID, 3 blinded tablets administered BID for 12 weeks

DRUG

CP-690,550

10mg BID, 3 blinded tablets administered BID for 12 weeks

DRUG

CP-690,550

15mg BID, 3 blinded tablets administered BID for 12 weeks

DRUG

CP-690,550

1mg BID, 3 blinded tablets administered BID for 12 weeks

DRUG

CP-690,550

3mg BID, 3 blinded tablets administered BID for 12 weeks

DRUG

CP-690,550

5mg BID, 3 blinded tablets administered BID for 12 weeks

Trial Locations (40)

Unknown

Pfizer Investigational Site, Nagoya

Pfizer Investigational Site, Chiba

Pfizer Investigational Site, Narashino

Pfizer Investigational Site, Yotukaidou

Pfizer Investigational Site, Fukuoka

Pfizer Investigational Site, Iiduka

Pfizer Investigational Site, Kitakyushu

Pfizer Investigational Site, Kurume

Pfizer Investigational Site, Sawara-ku

Pfizer Investigational Site, Fukushima

Pfizer Investigational Site, Takasaki

Pfizer Investigational Site, Higashihiroshima

Pfizer Investigational Site, Hiroshima

Pfizer Investigational Site, Asahikawa

Pfizer Investigational Site, Sapporo

Pfizer Investigational Site, Nishinomiya

Pfizer Investigational Site, Tsukuba

Pfizer Investigational Site, Sagamihara

Pfizer Investigational Site, Koushi

Pfizer Investigational Site, Kumamoto

Pfizer Investigational Site, Kyoto

Pfizer Investigational Site, Tsu

Pfizer Investigational Site, Sendai

Pfizer Investigational Site, Nagasaki

Pfizer Investigational Site, Ohmura

Pfizer Investigational Site, Sasebo

Pfizer Investigational Site, Kashihara

Pfizer Investigational Site, Ōita

Pfizer Investigational Site, Kawachi-Nagano

Pfizer Investigational Site, Osaka

Pfizer Investigational Site, Ureshino-shi

Pfizer Investigational Site, Kawagoe-shi

Pfizer Investigational Site, Kitamoto

Pfizer Investigational Site, Saitama

Pfizer Investigational Site, Arakawa-ku

Pfizer Investigational Site, Bunkyo-ku

Pfizer Investigational Site, Musashimurayama-shi

Pfizer Investigational Site, Setagaya-ku

Pfizer Investigational Site, Shinjyuku-ku

Pfizer Investigational Site, Takaoka